ClinicalTrials.gg
RecruitingNCT06943001Fit24+Updated Nov 9, 2026

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

An interventional study of Fit24+ in Obesity and Type 2 Diabetes, sponsored by Baylor College of Medicine. Recruiting at 1 site in United States. Open to participants aged 14 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Nov 9, 2026Study completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
14 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Obesity by Baylor College of Medicine — 2 open to participants now, 4 under way, none of them phase 3. Obesity · Baylor College of Medicine.

Planned enrollment
19th of 22
40 · median 130
Started
2025
with 2 others
No phase
18 of 27
2 open now
Registered
27th of 27
by date

Among the 27 studies in Obesity by Baylor College of Medicine, this one is the 19th largest by planned enrollment of the 22 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 27th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

2 of the 27 studies in Obesity by Baylor College of Medicine are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 14 Years to 16 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Obesity by Baylor College of Medicine, or all of them as a file.
02

Study summary

Hispanic adolescents are disproportionately burdened by type 2 diabetes (T2D). Social determinants of health (SDoH) serve as barriers to behavior change and participation in disease prevention efforts, especially among vulnerable adolescents. Telehealth is a potentially effective approach for delivering disease prevention programs as it addresses some SDoH like transportation, childcare needs, and parent work schedules. Unfortunately, there are no theory- or evidence-based telehealth diabetes prevention program for Hispanic adolescents. Therefore the purpose of this study is to adapt an evidence-based diabetes prevention program for delivery via telehealth and to test the feasibility of this study among Hispanic adolescents (12-16 years) with obesity.

Read the detailed description

Hispanic adolescents (N=24) and parents (N=24) will be invited to participate in at least three study activities across Phases 1-3 and will be compensated. In Phase 1, adolescents and parents will participate in separate focus groups. As an alternative to the focus group, youth will have the opportunity to answer the same questions via an interactive survey. The purpose of these focus groups is to elicit perceptions of Self-Determination Theory (SDT), text messages, desired program features, and gather quantitative data (survey) on technology use. For this study, the SDT constructs will include autonomy, relatedness, and competence. We will elicit feedback from adolescents and parents on strategies for feasibly engaging parents in the intervention. Focus group questions will be open-ended, allowing participants to fully describe their thoughts and preferences. In Phase 2, an expert panel will meet once during Phase 2 and once during Phase 3. In the first meeting, we will present initial program adaptations and findings from Phase 1 to explain the adaptations made. The panel will provide feedback and suggestions on additional modifications. In the second meeting, an example web-based nutrition education session will be reviewed, followed by a discussion on session content and delivery format, and a 10-item feedback survey. In Phase 3, a field usability testing with 12 of the original sample of 24 to provide feedback on a sample nutrition education session and the functionality of the activity tracker and text message components. Participants will be asked to use their own screen device to watch a sample session and answer questions regarding the acceptability, usability, and age and cultural appropriateness of the session. We will use a brief phone interview to clarify survey responses. To conduct field testing on the activity tracker and text messages, six participants will be given a Fitbit device and will self-select 1-2 peers who will provide support as they receive daily text messages that promote physical activity and sleep for four weeks through a groupchat platform, Remind. No data will be collected on the peers, they will simply provide support given that this was requested by youth in Phase 1. The other six participants will also be given a Fitbit device and will receive daily text messages that assist youth in intention planning to promote physical activity and sleep for four weeks. A chatbot will be developed by Mobile Coach and will be used to assist youth in setting behavioral goals and planning opportunities to be active or to improve sleep behaviors. This is a HIPAA secure chatbot that has no natural language processing or conversational capabilities and can only use text provided from our text message bank. A brief phone interview will be used to elicit perceptions on using the Fitbit, text message content, format, and frequency. We will also ask participants to identify barriers to using the Fitbit, suggestions for sustaining engagement, and the feasibility of tips and strategies shared via text.

Following these 3 phases, we will test the feasibility and acceptability of the intervention in a new sample of Hispanic youth (N=40). We will use a two-armed, pre-post study design. Following baseline assessments, adolescents will be randomized (1:1), stratified by sex, to the intervention or a control group. A priori feasibility criteria, process evaluation data, and exit interviews will be used to assess feasibility and acceptability. Participants will complete pre-and post-intervention assessments to examine preliminary efficacy and will be compensated for their time and participation.

Intervention The intervention promotes changes in diet and PA by: 1) fostering social support and 2) enhancing self-efficacy for healthy behavior changes. There are 12 pre-recorded nutrition and well-being sessions in Spanish and English lasting 20-40 minutes and hosted on an elearning platform, Learnworlds. This is a secure platform and each participant and their family members will have a secure, unique, password protected login. Only study participants will have access to Learnworlds via a website browser or its accompanying smartphone application. The platform includes a discussion board to share challenges and successes in behavior change, a recipes tab, and message system to ask instructors questions or report technical issues. An initial orientation will be used to introduce participants to the platform, give them study materials including intervention instructions, a Fitbit, a workbook, and food items for the food tasting experience. At orientation, the rules and privacy regulations for use of the activity tracker, text messaging, and expectations for program participation. Participants and their family will be asked to watch one session per week. Sessions reinforce healthy diet and physical activity (PA) habits, assist in setting weekly diet goals, problem-solving challenges in meeting goals, and an outline of session objectives. Participants will be incentivized through a point system for attendance, out of class assignments, participating in group discussions, and progress towards their individual health goals. Families will be encouraged to work together to prepare four recipes throughout the intervention to expose them to healthy recipes and teamwork. These recipes will include apples and peanut butter, oatmeal pancakes, tostadas, and lentils. The research team will provide families with oatmeal, peanut butter, black beans, and corn to make the recipes feasible to prepare. There will also be three live sessions held separately for parents and youth via Learnworlds to address questions regarding content and to foster social support among participants.

PA Component: Participants will receive a Fitbit Charge, which has shown high validity and reliability for assessing steps/day in adolescents. A chatbot developed by Mobile Coach will be used to assist youth in setting behavioral goals and planning opportunities to be active or to improve sleep behaviors. This is a HIPAA secure chatbot that has no natural language processing or conversational capabilities and can only use text provided from our text message bank. Starting week 2, the bot will assist youth in setting goals for steps/day based on their average daily step count from week 1. In successive weeks, participants will be guided to gradually increase their step count goals to meet or maintain current recommendations of at least 12,000 steps/day. Participants that average \<5,000 steps/day will be guided to increase their average by 600 steps/day each week, participants that average 5,000-11,999 steps/day will be guided to increase their steps/day goal by 10% of their week 1 average in successive weeks, and participants with ≥12,000 steps/day or greater will be instructed to maintain this average in successive weeks. Step count data from the Fitbit Charge will be continuously collected and wirelessly transmitted to Fitabase, a web-based platform. Fitabase aggregates daily step data and provides customized data reports. Implementers will provide feedback on goal attainment. Daily text messages will reinforce session content and promote autonomous motivation for PA. At the start of each week, texts will promote autonomy by encouraging adolescents to develop their own solutions for achieving their weekly PA goal. Mid-week texts will emphasize competence by acknowledging progression towards goals, providing evidence-based strategies for increasing PA, and reinforcing content from nutrition sessions. End of week texts will provide feedback on goal attainment and encourage adolescents to connect goal achievement to a personal value to build relatedness and a sense of connection. At the completion of the intervention, adolescents will return the Fitbit Charge to the study team.

Assessments Primary Outcomes: Feasibility is the primary outcome and will be evaluated using a priori criteria. Recruitment and Data Collection criteria will assess the feasibility of recruiting and retaining participants from community clinics. This will provide information on the availability of high-risk adolescents in community clinics and the feasibility of recruiting and engaging adolescents from this setting. The integrity of Study Protocol criteria will be used to identify the feasible and acceptable intervention doses. Technical Issues criteria will assess the feasibility of using Learnworlds, a Fitbit, and text messaging. Fidelity will be assessed as a team member will observe 75% of nutrition sessions and will complete fidelity checklists. Satisfaction will assess program acceptability. If feasibility criteria are satisfied it will be used to develop a future R01.

Secondary outcomes: Type 2 diabetes risk will be assessed using a point of care multi-assay analyzer, the Afinion 2 analyzer. Height and weight will be measured to the nearest 0.1cm and 0.1 kg, and used to calculate BMI% and BMI will be calculated as the percentage over the 95th percentile. Physical Activity (PA) will be assessed using a hip-worn accelerometer (wGT3X-BT, Actigraph). Participants will wear the accelerometer during wake time hours for 7 days. Participants will receive daily text messages to promote compliance in device wear. A valid day of wear will be defined as ≥10 hours of wear on ≥4 days, one of which has to be a weekend day. Dr. Soltero has extensive experience using accelerometers to assess PA and has achieved an 82% compliance rate in similar protocols. Data will be analyzed using Evenson cutpoints in the ActiLife software to report average minutes of PA/day. Assessments will be collected following the orientation at a convenient, private community center including Baker Ripley or the YMCA.

Tertiary Outcomes: Autonomous motivation for physical activity will be assessed using the Behavioral Regulation in Exercise Questionnaire. Both instruments have been validated among adolescents. We will also use the digital health equity survey at baseline to ensure the equitable implementation of a digital intervention among a high-risk, low socioeconomic population. Last, youth will complete the physical activity identity survey to understand the intervention's ability to improve one's belief that they can live an active life. At baseline, parents will be asked to complete a demographic survey.

Process Evaluation data will evaluate feasibility and identify contextual factors that impact implementation and outcomes. We will notate recruitment (e.g. staff time, materials, equipment), implementation, and retention efforts (e.g.participant calls, texts). We will also assess implementation fidelity, dose of intervention delivered and received, and potential contamination.Implementation fidelity, dose delivered, and dose received, will be defined by device wear and technical issues.

Control-youth in the control will receive a handout on diet and PA guidelines and setting SMART goals. Control youth will be given access to the nutrition education website after their participation as a control for 12-weeks. No additional data will be collected on control youth beyond the 12 week intervention period.

03

Conditions studied

  • Obesity and Type 2 Diabetes

Keywords

  • adolescents health
  • wearable sensors
  • user-centered design approac
  • T2D prevention
04

Who can participate

Ages eligible
14 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-report as Hispanic
  • obese, defined as percentile (BMI%) ≥ 95th percentile
  • ages of 12-16 years
  • owns his or her own cellphone

Exclusion criteria

Exclusion Criteria:

  • Taking a medication (i.e. ) or diagnosed with a condition (i.e. sleep apnea) that influences activity, sleep, and/or cognition
  • Recent hospitalization or injury that prevents normal physical activity
  • Pregnant
  • Currently enrolled in an exercise program or currently using a personal activity monitoring device like Fitbit
  • Taking medications or diagnosed with a condition that influences activity, glucose metabolism, and/or cognition.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention

    Nutrition Education: There are 12 pre-recorded nutrition and well-being sessions in Spanish and English lasting 20-40 minutes and hosted on an elearning platform, Learnworlds. This is a secure platform and each participant and their family members will have a secure, unique, password protected login. The platform includes a discussion board to share challenges and successes in behavior change, a recipes tab, and message system to ask instructors questions or report technical issues. Participants will receive a Fitbit Charge and access to a chatbot developed by Mobile Coach to assist youth in setting behavioral goals and planning opportunities to be active or to improve sleep behaviors. Mid-week texts will emphasize competence by acknowledging progression towards goals, providing evidence-based strategies for increasing PA, and reinforcing content from nutrition sessions. End of week texts will provide feedback on goal attainment.

    Behavioral: Fit24+

  • No intervention
    Control

    Youth in the control will receive a handout on diet and PA guidelines . Control youth will be given access to the nutrition education website after their participation as a control for 12-weeks. No additional data will be collected on control youth beyond the 12 week intervention period.

Interventions

  • BehavioralFit24+

    This is a digital diabetes prevention program for adolescents that leverages a Fitbit device, rule-based chatbot, and eLearning platform to deliver a comprehensive nutrition and physical activity lifestyle intervention to Hispanic adolescents with obesity.

06

What researchers measure

Primary outcomes

  1. Feasibility

    Feasibility is the primary outcome and will be evaluated using a priori criteria. Recruitment and Data Collection criteria will assess the feasibility of recruiting and retaining participants from community clinics. This will provide information on the availability of high-risk adolescents in community clinics and the feasibility of recruiting and engaging adolescents from this setting. The integrity of Study Protocol criteria will be used to identify the feasible and acceptable intervention doses. Technical Issues criteria will assess the feasibility of using Learnworlds, a Fitbit, and text messaging. Fidelity will be assessed as a team member will observe 75% of nutrition sessions and will complete fidelity checklists. Satisfaction will assess program acceptability. If feasibility criteria are satisfied it will be used to develop a future R01.

    Time frame: Change from Baseline to 12 weeks post-intervention

Secondary outcomes

  1. Hemoglobin A1c

    Type 2 diabetes risk will be assessed using a point of care multi-assay analyzer, the Afinion 2 analyzer.

    Time frame: Baseline and changes at 12-weeks post intervention

  2. Body mass index

    Height and weight will be measured to the nearest 0.1cm and 0.1 kg, and used to calculate BMI% and BMI will be calculated as the percentage over the 95th percentile.

    Time frame: Baseline and at 12-weeks post-intervention

  3. Physical Activity

    Physical Activity (PA) will be assessed using a hip-worn accelerometer (wGT3X-BT, Actigraph). Participants will wear the accelerometer during wake time hours for 7 days. Participants will receive daily text messages to promote compliance in device wear. A valid day of wear will be defined as ≥10 hours of wear on ≥4 days, one of which has to be a weekend day.

    Time frame: Baseline and at 12-weeks post-intervention

Other outcomes

  1. Autonomous Motivation

    Autonomous motivation for physical activity will be assessed using the Behavioral Regulation in Exercise Questionnaire. Both instruments have been validated among adolescents.

    Time frame: Baseline and at 12-weeks post-intervention

  2. Physical Activity identity

    Youth will complete the physical activity identity survey to understand the intervention's ability to improve one's belief that they can live an active life.

    Time frame: Baseline and at 12-weeks post-intervention.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Soltero EG, Partida M, Mihail S, Villanueva L, Lopez C, Musaad SM, O'Connor TM, Redondo MJ, Buman M, Thompson D. A Digital Diabetes Prevention Program for Hispanic Adolescents (Fit24+): Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2026 Apr 15;15:e75331. doi: 10.2196/75331. PubMed 41984597 ↗

Individual participant data

Plan to share: No — Anonymized, de-identified data will be shared through a Baylor College of Medicine identified data registry and available upon request.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Aug 2026, 16 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 16 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, on Nov 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2025
First posted
Apr 24, 2025
StartActual
Apr 12, 2025
Primary completionActual
Aug 31, 2026
CompletionEst.
Dec 31, 2026was Aug 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Study completion
Aug 31, 2026→Dec 31, 2026
Nov 9, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 41984597 ↗
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 41984597 ↗
    Study completion Aug 31, 2026→Dec 31, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06943001
Responsible party
Erica Gabrielle Soltero Ngwolo (Assistant Professor, Baylor College of Medicine) — Principal investigator
First posted
Apr 24, 2025
Start date
Apr 12, 2025
Primary completion
Aug 31, 2026
Completion
Dec 31, 2026 (estimated)
Last update
Nov 9, 2026

Study contacts

Erica Soltero, PhD
Contact
soltero@bcm.edu
402-910-0832

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion